Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 154.90
-0.65 (-0.42%)
At close: Apr 16, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 7.48 billion as of April 16, 2026. Its market cap has decreased by -19.99% in one year.
Market Cap
7.48B
Enterprise Value
8.68B
Revenue
6.20B
Ranking
n/a
PE Ratio
45.35
Stock Price
154.90
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 7.48B, an increase of 1,207.59%. That is a compound annual growth rate of 11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 7.51B | 3.77% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTK Healthcare | 12.35B |
| Lincoln Pharmaceuticals | 11.54B |
| Fermenta Biotech | 9.59B |
| Fredun Pharmaceuticals | 8.79B |
| Wanbury | 8.66B |
| Bharat Parenterals | 8.51B |
| Anuh Pharma | 7.85B |
| Sudarshan Pharma Industries | 7.39B |